Eligo Bioscience raised €28M in a Series B round in Dec 2023. The company is based in France. Investors in the round: Bpifrance, Khosla Ventures, Sanofi Ventures and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €28M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
